Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | XCR2BZ80N7 |
Action | Mechanism of Action | Reference |
---|---|---|
DISRUPTING AGENT | DNA disrupting agent | PubMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4298178 |
FDA SRS | XCR2BZ80N7 |